Tradestie Institutional Equity Comparison Engine
TENX vs PRTO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TENX Overall Edge
TENX Captures Institutional Edge (2โ2 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tenax Therapeutics, Inc. (TENX) driven by superior Valuation, Growth & Margin while PRTO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, TENX trades at 0.3x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PRTO at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, TENX sits in BREAKDOWN (24th %ile IV; Dealer Gamma Walls on Pro) against PRTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
TENX
TENX 0.3x vs PRTO N/M Fwd P/E
Growth & Margin Winner
TENX
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
PRTO
1Y -82.9% vs -3.4% ยท 52W Pos 0% vs 0%
Options & Structure Winner
PRTO
BREAKDOWN (24th %ile IV) vs UNCLASSIFIED (N/A IV)
TENX
NASDAQ
Tenax Therapeutics, Inc.
Pharmaceutical Preparations
$1.25
-10.07% 1D
Market Cap
$63.3M
1M Return
-28.98%
1Y Return
-82.92%
Forward P/E
0.3x
Unified AI Score
45.5 / 100
HOLD
Tech 33.0
Fund 57.0
Flow 66.0
Mom 60.0
PRTO
US Equity
PRTO
Institutional Equity
$24.45
-3.36% 1D
Market Cap
N/A
1M Return
-9.56%
1Y Return
-3.39%
Forward P/E
N/M
Unified AI Score
33.3 / 100
SELL
Tech 12.0
Fund 36.0
Flow 50.0
Mom 34.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TENX -82.92%
PRTO -3.39%
Spread: +87.68 pp (PRTO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
TENX TTM Op. Margin: 0.0%
PRTO TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TENX vs PRTO. Trailing 12-month operating profitability (TENX 0.0% vs PRTO N/A) and valuation multiples (TENX 0.3x vs PRTO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TENX | PRTO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $63.3M | N/A | Larger Scale | TENX |
| Trailing P/E Ratio Valuation | 0.3x | N/M | Lower Multiple | TENX |
| Forward P/E Ratio Valuation | 0.3x | N/M | Lower Multiple | TENX |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | TENX |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | TENX |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | TENX |
| Return on Equity (ROE) Capital Efficiency | -64.2% | N/A | Higher ROE | TENX |
| 52-Week Range Position Momentum | 0% ($1โ$19) | 0% ($24โ$29) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 1.42ฮฒ ยท 75% Vol | 0.89ฮฒ ยท 21% Vol | Lower Realized Risk | PRTO |
| Unified Institutional Score Composite Signal | 45.5 / 100 (HOLD) | 33.3 / 100 (SELL) | Higher Composite | TENX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TENX vs PRTO Buy Guide
TENX
BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
24th %ile
IV Regime
Compressed (<25th %ile)
PRTO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TENX nor PRTO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.